Login / Signup

First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA.

Basil S Lewis
Published in: European heart journal. Cardiovascular pharmacotherapy (2023)
Keyphrases
  • endothelial cells
  • low density lipoprotein
  • study protocol
  • clinical trial
  • induced pluripotent stem cells
  • phase iii
  • pluripotent stem cells
  • phase ii
  • smoking cessation
  • randomized controlled trial